Nicola Conran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nicola Conran has a total of 213 co-authors. Here are the top co-authors by number of shared publications:
Fernando F. Costa
Hematology Center, University of Campinas - UNICAMP, Campinas, São Paulo, Brazil
25 shared publications- Camila Bononi Almeida
Hematology Center, University of Campinas (UNICAMP), Campinas, Brazil
9 shared publications Fernando Ferreira Costa
Hematology and Hemotherapy Center, School of Medicine, University of Campinas, Campinas, São Paulo, Brazil
9 shared publications- Fabiola Traina
Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
8 shared publications Flavia C. Leonardo
Hematology Center, University of Campinas - UNICAMP, Campinas, São Paulo, Brazil
8 shared publicationsSara T. O. Saad
Hematology and Transfusion Center University of Campinas Campinas Brazil
7 shared publications
Latest Publications
- Open Access
- 6 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1796628
Editorial: Unraveling inflammatory pathways in sickle cell disease: molecular, cellular and translational insights
Since its identification as a "molecular disease" by Linus Pauling and colleagues in 1949 (1), the genetic and molecular foundations of sickle cell disease (SCD) have fascinated the research community. While the disease's underlying point mutation in the β-globin gene alters the structure and properties of hemoglobin, triggering erythrocyte sickling and hemolysis, we no longer view SCD strictly as a red blood cell (RBC) disorder (2). Current research now emphasizes coordinated interactions among multiple cell types and recognizes roles for innate immune pathways and inflammatory signaling in the disease (3,4). These pathways shape the cellular responses that drive vaso-occlusive processes and trigger progressive organ damage and the diverse complications of the disease.Leukocytes, particularly neutrophils and monocytes, are key to SCD pathophysiology.High leukocyte counts can predict disease severity (5,6), and murine model studies have demonstrated a physical role for these cells in orchestrating the vaso-occlusive process by adhering to the vascular wall and capturing circulating RBCs, leading to blood vessel obstruction (7,8).Beyond this mechanical disruption of microvascular hemodynamics, these cells function as primary inflammatory effectors that respond to disease-generated stimuli. One important focus of emerging research is neutrophil plasticity, where inflammatory signaling can influence the functional profile of these cells. Beyond neutrophil priming and activation in SCD, the accumulation of aged neutrophils (9) and low-density neutrophils (LDNs) (10) suggests functional shifts that may amplify disease pathology.Gaartman et al., in their contribution to this Research Topic, explored this plasticity by comparing the phenotype and function of neutrophils in groups of SCD patients to those of ethnicity-matched and non-matched controls. Their study confirmed significant inter-individual variation in neutrophil phenotypes, in association with limited functional changes. Notably, the authors highlighted the importance of using ethnically-matched controls to investigate neutrophil phenotype in SCD, a disease that is associated predominantly with African and African descendant populations.Expanding on this theme, Terrigno et al. compared neutrophil phenotypic and inflammatory profiles in SCD patients receiving "gold standard" therapies, namely hydroxyurea and chronic transfusion (CT). Supporting the known anti-inflammatory effects of hydroxyurea, lower neutrophil counts and numbers of aged neutrophils were identified in those taking this drug compared to the transfused group. This focus on aged neutrophils is reinforced by Gaartman et al.who detected a shift towards a seemingly "younger" neutrophil profile in patients during vasoocclusive crisis. These studies suggest that while hydroxyurea may reduce the aged neutrophil population during steady state, the crisis state may accelerate myeloid egression (as indicated by increased neutrophil counts) and the sequestration of the aged neutrophil population in the vasculature. Terrigno et al. also reported that hydroxyurea therapy was associated with lower levels of several circulating chemokines, compared to CT, suggesting distinct inflammatory skews between the two treatments. Authors conclude that combining hydroxyurea with CT may be warranted to ensure improved dampening of the systemic inflammatory state in patients on regular CT, especially given the high clinical severity that typically prompts the initiation of transfusion.another important cellular mediator of SCD pathophysiology (11). By comparing monocytes derived from diseased patients and healthy controls they show that circulating monocytes undergo sustained functional adaptation in response to repeated contact with sickled erythrocytes. This exposure promotes a coordinated shift in surface receptor expression that favors erythroid engagement, characterized by increased VCAM-1-mediated adhesion and attenuation of inhibitory signaling through reduced SIRP-α. Together, these changes lower the threshold for RBC internalization. Following erythrophagocytosis, monocytes activate conserved heme-handling pathways, including induction of heme oxygenase-1 and upregulation of ferroportin, enabling efficient degradation of hemoglobin-derived heme and subsequent iron export. The concurrent increase in CD206 expression suggests alignment with macrophage programs specialized for erythroid support and iron recycling. Through these interconnected mechanisms, circulating monocytes emerge as active regulators of RBC clearance and iron flux, linking erythrophagocytosis to inflammatory modulation and vascular dysfunction in SCD.Beyond the focus on leukocytes in SCD, endothelial activation and injury play a central role in disease pathophysiology. Recurrent ischemia-reperfusion events, together with the sustained release of damage-associated molecular patterns (DAMPs) and inflammatory mediators, promote endothelial dysfunction and detachment of cells from the vessel wall, leading to elevated levels of circulating endothelial cells (CECs) in SCD (12,13). In parallel, the chronic inflammatory milieu stimulates multiple cell types to release extracellular vesicles into the bloodstream, which can interact with and activate the endothelium, thereby contributing to vascular dysfunction and vaso-occlusive events (14,15).In this Research Topic, Beckman et al. rigorously validated pre-analytical and analytical methodologies for the quantification of CECs and endothelial extracellular vesicles (EEVs) in peripheral blood. Their study confirms and extends previous observations by demonstrating increased levels of both CECs and EEVs in SCD patients. Importantly, a detailed phenotypic analysis revealed that mature and resting CECs are the predominant subsets elevated in patients, whereas circulating EEVs largely originate from activated endothelial cells, as indicated by CD106 expression....
- 6 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1796628
Open AccessEditorial: Unraveling inflammatory pathways in sickle cell disease: molecular, cellular and translational insights
Since its identification as a "molecular disease" by Linus Pauling and colleagues in 1949 (1), the genetic and molecular foundations of sickle cell disease (SCD) have fascinated the research community. While the disease's underlying point mutation in the β-globin gene alters the structure and properties of hemoglobin, triggering erythrocyte sickling and hemolysis, we no longer view SCD strictly as a red blood cell (RBC) disorder (2). Current research now emphasizes coordinated interactions among multiple cell types and recognizes roles for innate immune pathways and inflammatory signaling in the disease (3,4). These pathways shape the cellular responses that drive vaso-occlusive processes and trigger progressive organ damage and the diverse complications of the disease.Leukocytes, particularly neutrophils and monocytes, are key to SCD pathophysiology.High leukocyte counts can predict disease severity (5,6), and murine model studies have demonstrated a physical role for these cells in orchestrating the vaso-occlusive process by adhering to the vascular wall and capturing circulating RBCs, leading to blood vessel obstruction (7,8).Beyond this mechanical disruption of microvascular hemodynamics, these cells function as primary inflammatory effectors that respond to disease-generated stimuli. One important focus of emerging research is neutrophil plasticity, where inflammatory signaling can influence the functional profile of these cells. Beyond neutrophil priming and activation in SCD, the accumulation of aged neutrophils (9) and low-density neutrophils (LDNs) (10) suggests functional shifts that may amplify disease pathology.Gaartman et al., in their contribution to this Research Topic, explored this plasticity by comparing the phenotype and function of neutrophils in groups of SCD patients to those of ethnicity-matched and non-matched controls. Their study confirmed significant inter-individual variation in neutrophil phenotypes, in association with limited functional changes. Notably, the authors highlighted the importance of using ethnically-matched controls to investigate neutrophil phenotype in SCD, a disease that is associated predominantly with African and African descendant populations.Expanding on this theme, Terrigno et al. compared neutrophil phenotypic and inflammatory profiles in SCD patients receiving "gold standard" therapies, namely hydroxyurea and chronic transfusion (CT). Supporting the known anti-inflammatory effects of hydroxyurea, lower neutrophil counts and numbers of aged neutrophils were identified in those taking this drug compared to the transfused group. This focus on aged neutrophils is reinforced by Gaartman et al.who detected a shift towards a seemingly "younger" neutrophil profile in patients during vasoocclusive crisis. These studies suggest that while hydroxyurea may reduce the aged neutrophil population during steady state, the crisis state may accelerate myeloid egression (as indicated by increased neutrophil counts) and the sequestration of the aged neutrophil population in the vasculature. Terrigno et al. also reported that hydroxyurea therapy was associated with lower levels of several circulating chemokines, compared to CT, suggesting distinct inflammatory skews between the two treatments. Authors conclude that combining hydroxyurea with CT may be warranted to ensure improved dampening of the systemic inflammatory state in patients on regular CT, especially given the high clinical severity that typically prompts the initiation of transfusion.another important cellular mediator of SCD pathophysiology (11). By comparing monocytes derived from diseased patients and healthy controls they show that circulating monocytes undergo sustained functional adaptation in response to repeated contact with sickled erythrocytes. This exposure promotes a coordinated shift in surface receptor expression that favors erythroid engagement, characterized by increased VCAM-1-mediated adhesion and attenuation of inhibitory signaling through reduced SIRP-α. Together, these changes lower the threshold for RBC internalization. Following erythrophagocytosis, monocytes activate conserved heme-handling pathways, including induction of heme oxygenase-1 and upregulation of ferroportin, enabling efficient degradation of hemoglobin-derived heme and subsequent iron export. The concurrent increase in CD206 expression suggests alignment with macrophage programs specialized for erythroid support and iron recycling. Through these interconnected mechanisms, circulating monocytes emerge as active regulators of RBC clearance and iron flux, linking erythrophagocytosis to inflammatory modulation and vascular dysfunction in SCD.Beyond the focus on leukocytes in SCD, endothelial activation and injury play a central role in disease pathophysiology. Recurrent ischemia-reperfusion events, together with the sustained release of damage-associated molecular patterns (DAMPs) and inflammatory mediators, promote endothelial dysfunction and detachment of cells from the vessel wall, leading to elevated levels of circulating endothelial cells (CECs) in SCD (12,13). In parallel, the chronic inflammatory milieu stimulates multiple cell types to release extracellular vesicles into the bloodstream, which can interact with and activate the endothelium, thereby contributing to vascular dysfunction and vaso-occlusive events (14,15).In this Research Topic, Beckman et al. rigorously validated pre-analytical and analytical methodologies for the quantification of CECs and endothelial extracellular vesicles (EEVs) in peripheral blood. Their study confirms and extends previous observations by demonstrating increased levels of both CECs and EEVs in SCD patients. Importantly, a detailed phenotypic analysis revealed that mature and resting CECs are the predominant subsets elevated in patients, whereas circulating EEVs largely originate from activated endothelial cells, as indicated by CD106 expression....
- 31 December 2025
- Published by Elsevier in Experimental Hematology
- Vol. 156, 105366
Anti-IL-18 immunotherapy decreases inflammatory and vaso-occlusive responses in mice with sickle cell disease
- 31 December 2025
- Published by Elsevier in Experimental Hematology
- Vol. 156, 105366
Anti-IL-18 immunotherapy decreases inflammatory and vaso-occlusive responses in mice with sickle cell disease
- 1 October 2025
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 329 (4) , H920-H938
Caspase-1 activation drives vascular inflammatory processes and hypoperfusion in intravascular hemolysis
This study identifies caspase-1 as a driver of the microvascular leukocyte recruitment and hypoperfusion that is induced by intravascular hemolysis (IVH). Using in vivo models and heme-stimulated endothelial cells, we show that IVH rapidly induces caspase-1-dependent endothelial-leukocyte recruitment, microvascular dysfunction, and also IL-1β release. Oxidative stress promotes heme-induced endothelial caspase-1 activation and adhesion molecule expression, potentially amplifying vascular dysfunction. These findings provide insight into IVH-driven pathology in hemolytic disorders, including sickle cell disease.
- 1 October 2025
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 329 (4) , H920-H938
Caspase-1 activation drives vascular inflammatory processes and hypoperfusion in intravascular hemolysis
This study identifies caspase-1 as a driver of the microvascular leukocyte recruitment and hypoperfusion that is induced by intravascular hemolysis (IVH). Using in vivo models and heme-stimulated endothelial cells, we show that IVH rapidly induces caspase-1-dependent endothelial-leukocyte recruitment, microvascular dysfunction, and also IL-1β release. Oxidative stress promotes heme-induced endothelial caspase-1 activation and adhesion molecule expression, potentially amplifying vascular dysfunction. These findings provide insight into IVH-driven pathology in hemolytic disorders, including sickle cell disease.
- Open Access
- 27 May 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (11) , 5133
Circulating Monocytes Contribute to Erythrocyte Clearance in Polycythemia Vera
Erythropoiesis is increased in polycythemia vera (PV), with proliferation of erythroid precursors, and macrophages from erythroblastic islands play a key role in this process. Circulating monocytes were shown to perform some of the macrophage’s functions in normal conditions, but their participation during stress erythropoiesis, as in PV, is yet to be determined. In this study, we evaluated the monocytes from the blood of healthy donors or PV patients regarding their phenotype, involvement in the clearance of erythroid cells, and their expression of iron-related molecules. We showed that circulating monocytes from PV patients contained red blood cell-derived material, which correlated with a reduction in Sirp-ɑ expression, indicating that they play a role in erythroid cell clearance in PV. Both PV monocytes and PV erythroid cells seem to influence the increase in erythrophagocytosis. The enhanced expression of heme-oxygenase-1 and ferroportin post-phagocytosis suggests their capability for heme degradation and externalization of residual iron. Moreover, PV monocytes presented higher expression of CD169, CD163, and VCAM-1, which are involved with erythroid adhesion, and they influenced in vitro erythroid cell line differentiation, suggesting that they may interfere with erythropoiesis in PV. Our findings highlight the similarities between PV monocytes and macrophages of erythroblastic islands. These insights contribute to a deeper understanding of erythrophagocytosis and erythropoiesis in the disease, offering new perspectives for advances in the field.
- 27 May 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (11) , 5133
Open AccessCirculating Monocytes Contribute to Erythrocyte Clearance in Polycythemia Vera
Erythropoiesis is increased in polycythemia vera (PV), with proliferation of erythroid precursors, and macrophages from erythroblastic islands play a key role in this process. Circulating monocytes were shown to perform some of the macrophage’s functions in normal conditions, but their participation during stress erythropoiesis, as in PV, is yet to be determined. In this study, we evaluated the monocytes from the blood of healthy donors or PV patients regarding their phenotype, involvement in the clearance of erythroid cells, and their expression of iron-related molecules. We showed that circulating monocytes from PV patients contained red blood cell-derived material, which correlated with a reduction in Sirp-ɑ expression, indicating that they play a role in erythroid cell clearance in PV. Both PV monocytes and PV erythroid cells seem to influence the increase in erythrophagocytosis. The enhanced expression of heme-oxygenase-1 and ferroportin post-phagocytosis suggests their capability for heme degradation and externalization of residual iron. Moreover, PV monocytes presented higher expression of CD169, CD163, and VCAM-1, which are involved with erythroid adhesion, and they influenced in vitro erythroid cell line differentiation, suggesting that they may interfere with erythropoiesis in PV. Our findings highlight the similarities between PV monocytes and macrophages of erythroblastic islands. These insights contribute to a deeper understanding of erythrophagocytosis and erythropoiesis in the disease, offering new perspectives for advances in the field.
- Open Access
Caspase-Driven Microvascular Inflammation and Hypoperfusion in Intravascular Hemolysis: Roles of Leukocyte and Endothelial Activation
Intravascular hemolysis (IVH), a pathological process associated with various conditions, triggers vascular responses; however, the molecular and cellular mechanisms driving this process remain unclear. To explore the role of NLRP3 inflammasome- and caspase-dependent pathways in IVH-induced inflammation, we used in vivo models of acute and chronic IVH, alongside hemestimulation of endothelial cells, thereby isolating this disease mechanism from its etiological causes. Acute IVH induced immediate inflammatory responses in C57BL/6 mice, marked by the release of pro-inflammatory molecules, including IL-1β, within just 15 minutes and NLRP3-dependent caspase activation in circulating leukocytes. Chronic IVH processes in mice elevated liver monocyte-derived macrophage caspase activity and NLRP3 protein expression. In turn, acute IVH impaired cutaneous microvascular blood flow and perfusion, and induced microvascular leukocyte recruitment, which were both caspase-1-dependent. Acute IVH induced time-dependent CD11b-integrin-subunit presentation on leukocytes, while heme stimulation augmented endothelial cell adhesion molecule expression, potentially promoting leukocyte recruitment. This endothelial activation was associated with reactive oxygen species generation, which promoted caspase-1 activation and was key to adhesion molecule upregulation. Our findings highlight a role for inflammasome-/caspase-dependent pathways in hemolytic inflammation, contributing to microvascular leukocyte recruitment and particularly to cutaneous hypoperfusion, a consequence that could facilitate the progression of skin lesions. Targeting caspase-dependent pathways and their downstream effects in disorders that display IVH may offer therapeutic potential for maintaining endothelial integrity, reducing leukocyte activation, and mitigating ischemic injury. NEW & NOTEWORTHY: This study identifies caspase-1 as a driver of the vascular inflammation and hypoperfusion induced by intravascular hemolysis (IVH). Using in vivo models and heme-stimulated endothelial cells, we show that hemolysis rapidly induces caspase-1-dependent endothelial-leukocyte recruitment, microvascular dysfunction, and also IL-1β release. Oxidative stress promotes heme-induced endothelial caspase-1 activation and adhesion molecule expression, potentially amplifying vascular dysfunction. These findings provide insight into IVH-driven pathology in hemolytic disorders, including sickle cell disease.
Open AccessCaspase-Driven Microvascular Inflammation and Hypoperfusion in Intravascular Hemolysis: Roles of Leukocyte and Endothelial Activation
Intravascular hemolysis (IVH), a pathological process associated with various conditions, triggers vascular responses; however, the molecular and cellular mechanisms driving this process remain unclear. To explore the role of NLRP3 inflammasome- and caspase-dependent pathways in IVH-induced inflammation, we used in vivo models of acute and chronic IVH, alongside hemestimulation of endothelial cells, thereby isolating this disease mechanism from its etiological causes. Acute IVH induced immediate inflammatory responses in C57BL/6 mice, marked by the release of pro-inflammatory molecules, including IL-1β, within just 15 minutes and NLRP3-dependent caspase activation in circulating leukocytes. Chronic IVH processes in mice elevated liver monocyte-derived macrophage caspase activity and NLRP3 protein expression. In turn, acute IVH impaired cutaneous microvascular blood flow and perfusion, and induced microvascular leukocyte recruitment, which were both caspase-1-dependent. Acute IVH induced time-dependent CD11b-integrin-subunit presentation on leukocytes, while heme stimulation augmented endothelial cell adhesion molecule expression, potentially promoting leukocyte recruitment. This endothelial activation was associated with reactive oxygen species generation, which promoted caspase-1 activation and was key to adhesion molecule upregulation. Our findings highlight a role for inflammasome-/caspase-dependent pathways in hemolytic inflammation, contributing to microvascular leukocyte recruitment and particularly to cutaneous hypoperfusion, a consequence that could facilitate the progression of skin lesions. Targeting caspase-dependent pathways and their downstream effects in disorders that display IVH may offer therapeutic potential for maintaining endothelial integrity, reducing leukocyte activation, and mitigating ischemic injury. NEW & NOTEWORTHY: This study identifies caspase-1 as a driver of the vascular inflammation and hypoperfusion induced by intravascular hemolysis (IVH). Using in vivo models and heme-stimulated endothelial cells, we show that hemolysis rapidly induces caspase-1-dependent endothelial-leukocyte recruitment, microvascular dysfunction, and also IL-1β release. Oxidative stress promotes heme-induced endothelial caspase-1 activation and adhesion molecule expression, potentially amplifying vascular dysfunction. These findings provide insight into IVH-driven pathology in hemolytic disorders, including sickle cell disease.
- 4 March 2025
- Published by Wiley in British Journal of Haematology
- Vol. 206 (5) , 1518-1522
Acute intravascular haemolysis rapidly shifts the balance of angiogenic factors and accelerates neovascularization in vivo
- 4 March 2025
- Published by Wiley in British Journal of Haematology
- Vol. 206 (5) , 1518-1522
Acute intravascular haemolysis rapidly shifts the balance of angiogenic factors and accelerates neovascularization in vivo
- Open Access
- 21 November 2024
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 110 (3) , 725-738
Targeting P-selectin and interleukin-1β in mice with sickle cell disease: effects on vaso-occlusion, liver injury and organ iron deposition
Continuous vaso-occlusive and inflammatory processes cause extensive end-organ damage in adults with sickle cell disease (SCD), and there is little evidence that long-term hydroxyurea therapy prevents this. In initial trials, P-selectin blockade with crizanlizumab reduced SCD vaso-occlusive crisis frequency, and interleukin (IL)-1β inhibition in SCD patients, using canakinumab, lowered inflammatory markers. We used murine SCD models to examine the effects of acute and chronic blockade of P-selectin and of IL-1β on vaso-occlusive events, their inflammatory profile and organ health. Both approaches improved impaired cutaneous microvascular perfusion in SCD mice by reducing TNF-α-induced vaso-occlusion. Acute P-selectin blockade markedly reduced TNF-α-induced neutrophil-platelet aggregate formation in SCD mice, and decreased leukocyte- rolling movements in the microvasculature, while acute IL-1β inhibition attenuated microvascular leukocyte adhesion. Six weeks of IL-1β-blocking immunotherapy improved the inflammatory profile of SCD mice, considerably reduced hepatic fibrosis and provided some relief from lung injury. In contrast, although P-selectin blockade reduced glomerular congestion, no significant benefit to overall organ pathology was observed. Unexpectedly, while combining the two immunotherapies reduced microvascular occlusion, their prolonged use caused acute liver injury. Notably, inhibition of IL-1β, but not of P-selectin, remarkably decreased hemosiderosis, in association with reduced tissue macrophage infiltration and the correction of biomarkers of dysregulated iron turnover. Our findings suggest that the attenuation of inflammation, as well as of vaso- occlusive processes, may be crucial for mitigating organ damage in SCD. Future trials should explore the ability of cytokine blockade to prevent multi-organ damage in patients with SCD, beyond evaluating vaso-occlusive crisis frequency.
- 21 November 2024
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 110 (3) , 725-738
Open AccessTargeting P-selectin and interleukin-1β in mice with sickle cell disease: effects on vaso-occlusion, liver injury and organ iron deposition
Continuous vaso-occlusive and inflammatory processes cause extensive end-organ damage in adults with sickle cell disease (SCD), and there is little evidence that long-term hydroxyurea therapy prevents this. In initial trials, P-selectin blockade with crizanlizumab reduced SCD vaso-occlusive crisis frequency, and interleukin (IL)-1β inhibition in SCD patients, using canakinumab, lowered inflammatory markers. We used murine SCD models to examine the effects of acute and chronic blockade of P-selectin and of IL-1β on vaso-occlusive events, their inflammatory profile and organ health. Both approaches improved impaired cutaneous microvascular perfusion in SCD mice by reducing TNF-α-induced vaso-occlusion. Acute P-selectin blockade markedly reduced TNF-α-induced neutrophil-platelet aggregate formation in SCD mice, and decreased leukocyte- rolling movements in the microvasculature, while acute IL-1β inhibition attenuated microvascular leukocyte adhesion. Six weeks of IL-1β-blocking immunotherapy improved the inflammatory profile of SCD mice, considerably reduced hepatic fibrosis and provided some relief from lung injury. In contrast, although P-selectin blockade reduced glomerular congestion, no significant benefit to overall organ pathology was observed. Unexpectedly, while combining the two immunotherapies reduced microvascular occlusion, their prolonged use caused acute liver injury. Notably, inhibition of IL-1β, but not of P-selectin, remarkably decreased hemosiderosis, in association with reduced tissue macrophage infiltration and the correction of biomarkers of dysregulated iron turnover. Our findings suggest that the attenuation of inflammation, as well as of vaso- occlusive processes, may be crucial for mitigating organ damage in SCD. Future trials should explore the ability of cytokine blockade to prevent multi-organ damage in patients with SCD, beyond evaluating vaso-occlusive crisis frequency.
- 27 April 2023
- Published by Elsevier in Vascular Pharmacology
- Vol. 150, 107176
Molecular and cellular effects of in vivo chronic intravascular hemolysis and anti-inflammatory therapeutic approaches
- 27 April 2023
- Published by Elsevier in Vascular Pharmacology
- Vol. 150, 107176
Molecular and cellular effects of in vivo chronic intravascular hemolysis and anti-inflammatory therapeutic approaches
- 3 April 2023
- Published by Wiley in British Journal of Haematology
- Vol. 202 (3) , 657-668
Piezo1 activation augments sickling propensity and the adhesive properties of sickle red blood cells in a calcium‐dependent manner
Summary: Haemoglobin S polymerization in the red blood cells (RBCs) of individuals with sickle cell anaemia (SCA) can cause RBC sickling and cellular alterations. Piezo1 is a mechanosensitive protein that modulates intracellular calcium (Ca2+) influx, and its activation has been associated with increased RBC surface membrane phosphatidylserine (PS) exposure. Hypothesizing that Piezo1 activation, and ensuing Gárdos channel activity, alter sickle RBC properties, RBCs from patients with SCA were incubated with the Piezo1 agonist, Yoda1 (0.1–10 μM). Oxygen‐gradient ektacytometry and membrane potential measurement showed that Piezo1 activation significantly decreased sickle RBC deformability, augmented sickling propensity, and triggered pronounced membrane hyperpolarization, in association with Gárdos channel activation and Ca2+ influx. Yoda1 induced Ca2+‐dependent adhesion of sickle RBCs to laminin, in microfluidic assays, mediated by increased BCAM binding affinity. Furthermore, RBCs from SCA patients that were homo−/heterozygous for the rs59446030 gain‐of‐function Piezo1 variant demonstrated enhanced sickling under deoxygenation and increased PS exposure. Thus, Piezo1 stimulation decreases sickle RBC deformability, and increases the propensities of these cells to sickle upon deoxygenation and adhere to laminin. Results support a role of Piezo1 in some of the RBC properties that contribute to SCA vaso‐occlusion, indicating that Piezo1 may represent a potential therapeutic target molecule for this disease.
- 3 April 2023
- Published by Wiley in British Journal of Haematology
- Vol. 202 (3) , 657-668
Piezo1 activation augments sickling propensity and the adhesive properties of sickle red blood cells in a calcium‐dependent manner
Summary: Haemoglobin S polymerization in the red blood cells (RBCs) of individuals with sickle cell anaemia (SCA) can cause RBC sickling and cellular alterations. Piezo1 is a mechanosensitive protein that modulates intracellular calcium (Ca2+) influx, and its activation has been associated with increased RBC surface membrane phosphatidylserine (PS) exposure. Hypothesizing that Piezo1 activation, and ensuing Gárdos channel activity, alter sickle RBC properties, RBCs from patients with SCA were incubated with the Piezo1 agonist, Yoda1 (0.1–10 μM). Oxygen‐gradient ektacytometry and membrane potential measurement showed that Piezo1 activation significantly decreased sickle RBC deformability, augmented sickling propensity, and triggered pronounced membrane hyperpolarization, in association with Gárdos channel activation and Ca2+ influx. Yoda1 induced Ca2+‐dependent adhesion of sickle RBCs to laminin, in microfluidic assays, mediated by increased BCAM binding affinity. Furthermore, RBCs from SCA patients that were homo−/heterozygous for the rs59446030 gain‐of‐function Piezo1 variant demonstrated enhanced sickling under deoxygenation and increased PS exposure. Thus, Piezo1 stimulation decreases sickle RBC deformability, and increases the propensities of these cells to sickle upon deoxygenation and adhere to laminin. Results support a role of Piezo1 in some of the RBC properties that contribute to SCA vaso‐occlusion, indicating that Piezo1 may represent a potential therapeutic target molecule for this disease.
- Open Access
- 28 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (7) , 6333
Role of Macrophages in Sickle Cell Disease Erythrophagocytosis and Erythropoiesis
Sickle cell disease (SCD) is an inherited blood disorder caused by a β-globin gene point mutation that results in the production of sickle hemoglobin that polymerizes upon deoxygenation, causing the sickling of red blood cells (RBCs). RBC deformation initiates a sequence of events leading to multiple complications, such as hemolytic anemia, vaso-occlusion, chronic inflammation, and tissue damage. Macrophages participate in extravascular hemolysis by removing damaged RBCs, hence preventing the release of free hemoglobin and heme, and triggering inflammation. Upon erythrophagocytosis, macrophages metabolize RBC-derived hemoglobin, activating mechanisms responsible for recycling iron, which is then used for the generation of new RBCs to try to compensate for anemia. In the bone marrow, macrophages can create specialized niches, known as erythroblastic islands (EBIs), which regulate erythropoiesis. Anemia and inflammation present in SCD may trigger mechanisms of stress erythropoiesis, intensifying RBC generation by expanding the number of EBIs in the bone marrow and creating new ones in extramedullary sites. In the current review, we discuss the distinct mechanisms that could induce stress erythropoiesis in SCD, potentially shifting the macrophage phenotype to an inflammatory profile, and changing their supporting role necessary for the proliferation and differentiation of erythroid cells in the disease. The knowledge of the soluble factors, cell surface and intracellular molecules expressed by EBI macrophages that contribute to begin and end the RBC’s lifespan, as well as the understanding of their signaling pathways in SCD, may reveal potential targets to control the pathophysiology of the disease.
- 28 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (7) , 6333
Open AccessRole of Macrophages in Sickle Cell Disease Erythrophagocytosis and Erythropoiesis
Sickle cell disease (SCD) is an inherited blood disorder caused by a β-globin gene point mutation that results in the production of sickle hemoglobin that polymerizes upon deoxygenation, causing the sickling of red blood cells (RBCs). RBC deformation initiates a sequence of events leading to multiple complications, such as hemolytic anemia, vaso-occlusion, chronic inflammation, and tissue damage. Macrophages participate in extravascular hemolysis by removing damaged RBCs, hence preventing the release of free hemoglobin and heme, and triggering inflammation. Upon erythrophagocytosis, macrophages metabolize RBC-derived hemoglobin, activating mechanisms responsible for recycling iron, which is then used for the generation of new RBCs to try to compensate for anemia. In the bone marrow, macrophages can create specialized niches, known as erythroblastic islands (EBIs), which regulate erythropoiesis. Anemia and inflammation present in SCD may trigger mechanisms of stress erythropoiesis, intensifying RBC generation by expanding the number of EBIs in the bone marrow and creating new ones in extramedullary sites. In the current review, we discuss the distinct mechanisms that could induce stress erythropoiesis in SCD, potentially shifting the macrophage phenotype to an inflammatory profile, and changing their supporting role necessary for the proliferation and differentiation of erythroid cells in the disease. The knowledge of the soluble factors, cell surface and intracellular molecules expressed by EBI macrophages that contribute to begin and end the RBC’s lifespan, as well as the understanding of their signaling pathways in SCD, may reveal potential targets to control the pathophysiology of the disease.